Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 175,475 | 170,018 | 170,111 | 162,887 | 158,212 |
| Cost of Goods | 123,773 | 119,318 | 119,941 | 118,361 | 113,635 |
| Gross Profit | 51,702 | 50,700 | 50,170 | 44,526 | 44,577 |
| Operating Expenses | 19,026 | 18,702 | 18,706 | 18,218 | 17,857 |
| Operating Income | 33,449 | 32,316 | 32,405 | 26,669 | 27,355 |
| Interest Expense | 3,296 | 3,120 | 2,717 | 2,707 | 2,692 |
| Pre-tax Income | 30,153 | 29,196 | 29,688 | 23,962 | 24,663 |
| Income Tax | 5,020 | 5,273 | 8,016 | 3,595 | 3,709 |
| Net Income Continuous | 25,133 | 23,923 | 21,672 | 20,367 | 20,954 |
| Net Income Discontinuous | -328 | -346 | -20 | 686 | 1,755 |
| Minority Interests | 53 | 50 | -39 | -33 | 19 |
| Net Income | $24,752 | $23,527 | $21,691 | $21,086 | $22,690 |
| EPS Basic Total Ops | 0.56 | 0.53 | 0.49 | 0.48 | 0.51 |
| EPS Basic Continuous Ops | 0.57 | 0.54 | 0.49 | 0.46 | 0.47 |
| EPS Basic Discontinuous Ops | -0.01 | -0.01 | 0.00 | 0.02 | 0.04 |
| EPS Diluted Total Ops | 0.56 | 0.53 | 0.49 | 0.48 | 0.51 |
| EPS Diluted Continuous Ops | 0.57 | 0.54 | 0.49 | 0.46 | 0.47 |
| EPS Diluted Discontinuous Ops | -0.01 | -0.01 | 0.00 | 0.02 | 0.04 |
| EBITDA(a) | $39,317 | $38,134 | $38,443 | $32,662 | $33,544 |